SAT1 and hepatocellular carcinoma: To verify the efficacy of our predictive model, we validated the expression of PPT1, DAB2, FTL, and SAT1 using PCR in HCC cells (Hep3B and Huh7), as well as human normal hepatocytes (THLE-2).